Skip to main content
Top
Gepubliceerd in: Quality of Life Research 9/2015

01-09-2015 | Brief Communication

Reliability of the autoimmune bullous disease quality of life (ABQOL) questionnaire in the USA

Auteurs: Deshan F. Sebaratnam, Joyce Okawa, Aimee Payne, Dédée F. Murrell, Victoria P. Werth

Gepubliceerd in: Quality of Life Research | Uitgave 9/2015

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

To evaluate the reliability of the autoimmune bullous diseases quality of life (ABQOL) questionnaire in a North American patient cohort.

Methods

Patients attending the dermatology clinics of the University of Pennsylvania with a histological diagnosis of an autoimmune bullous disease (AIBD) and self-reported proficiency in English were recruited to participate in the study. Patients completed the ABQOL questionnaire at Day 0 and Day 3. Internal consistency was calculated through Cronbach’s alpha. Test–retest reliability was determined by the intraclass correlation coefficient.

Results

Of the 45 patients enrolled in the study, 39 patients (87 %) participated to completion. The mean age was 60.7 years with an equal sex distribution observed. Patients had a range of AIBD including pemphigus vulgaris, bullous pemphigoid, pemphigus foliaceus, epidermolysis bullosa acquisita, mucous membrane pemphigoid and linear IgA disease. Cronbach’s alpha was calculated to be 0.90. The intraclass correlation coefficient was calculated to be 0.93 (95 % confidence interval 0.88–0.94).

Conclusion

The ABQOL was found to be reliable tested by internal consistency and test–retest reliability in an American patient cohort. It represents a promising disease-specific outcome measure for patients with AIBD.
Literatuur
1.
go back to reference Sebaratnam, D. F., McMillan, J. W., Werth, V. P., & Murrell, D. F. (2012). Quality of life in patients with bullous dermatoses. Clinics in Dermatology, 30(1), 103–107.PubMedCrossRef Sebaratnam, D. F., McMillan, J. W., Werth, V. P., & Murrell, D. F. (2012). Quality of life in patients with bullous dermatoses. Clinics in Dermatology, 30(1), 103–107.PubMedCrossRef
2.
go back to reference Chen, S. (2007). Dermatology quality of life instruments: Sorting out the quagmire. Journal of Investigative Dermatology, 127(12), 2695–2696.PubMedCrossRef Chen, S. (2007). Dermatology quality of life instruments: Sorting out the quagmire. Journal of Investigative Dermatology, 127(12), 2695–2696.PubMedCrossRef
3.
go back to reference Sebaratnam, D. F., Hanna, A. M., Chee, S. N., et al. (2013). Development of a quality-of-life instrument for autoimmune bullous disease: The autoimmune bullous disease quality of life questionnaire. JAMA Dermatology, 149(1), 1186–1191.PubMedCrossRef Sebaratnam, D. F., Hanna, A. M., Chee, S. N., et al. (2013). Development of a quality-of-life instrument for autoimmune bullous disease: The autoimmune bullous disease quality of life questionnaire. JAMA Dermatology, 149(1), 1186–1191.PubMedCrossRef
4.
go back to reference Karpouzis, A., Vamvassakis, E., Stavrianeas, N., et al. (2002). Ultrastructural immunocytochemistry of autoimmune bullous diseases. Australasian Journal of Dermatology, 43(2), 113–119.PubMedCrossRef Karpouzis, A., Vamvassakis, E., Stavrianeas, N., et al. (2002). Ultrastructural immunocytochemistry of autoimmune bullous diseases. Australasian Journal of Dermatology, 43(2), 113–119.PubMedCrossRef
5.
go back to reference Sebaratnam, D. F., & Murrell, D. F. (2009). Treatment of pemphigus vulgaris and pemphigus foliaceus. Expert Review of Dermatology, 4(5), 469–481.CrossRef Sebaratnam, D. F., & Murrell, D. F. (2009). Treatment of pemphigus vulgaris and pemphigus foliaceus. Expert Review of Dermatology, 4(5), 469–481.CrossRef
6.
go back to reference Grob, J. J. (2007). Why are quality of life instruments not recognized as reference measures in therapeutic trials of chronic skin disorders? Journal of Investigative Dermatology, 127(10), 2299–2301.PubMedCrossRef Grob, J. J. (2007). Why are quality of life instruments not recognized as reference measures in therapeutic trials of chronic skin disorders? Journal of Investigative Dermatology, 127(10), 2299–2301.PubMedCrossRef
7.
go back to reference Prinsen, C. A. C., de Korte, J., Augustin, M., et al. (2013). Measurement of health-related quality of life in dermatological research and practice: Outcome of the EADV taskforce on quality of life. Journal of the European Academy of Dermatology and Venereology, 27(10), 1195–1203.PubMed Prinsen, C. A. C., de Korte, J., Augustin, M., et al. (2013). Measurement of health-related quality of life in dermatological research and practice: Outcome of the EADV taskforce on quality of life. Journal of the European Academy of Dermatology and Venereology, 27(10), 1195–1203.PubMed
8.
go back to reference Rosenbach, M., Murrell, D. F., Bystryn, J. C., et al. (2009). Reliability and convergent validity of two outcome instruments for pemphigus. Journal of Investigative Dermatology, 129(10), 2404–2410.PubMedCentralPubMedCrossRef Rosenbach, M., Murrell, D. F., Bystryn, J. C., et al. (2009). Reliability and convergent validity of two outcome instruments for pemphigus. Journal of Investigative Dermatology, 129(10), 2404–2410.PubMedCentralPubMedCrossRef
9.
go back to reference Clemens, S., Begum, N., Harper, C., et al. (2014). A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA. Quality of Life Research, 23(8), 2375–2381.PubMedCrossRef Clemens, S., Begum, N., Harper, C., et al. (2014). A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA. Quality of Life Research, 23(8), 2375–2381.PubMedCrossRef
10.
go back to reference Sebaratnam, D. F., Frew, J. W., Davatchi, F., et al. (2012). Quality-of-life measurement in blistering diseases. Dermatologic Clinics, 30(2), 301–307.PubMedCrossRef Sebaratnam, D. F., Frew, J. W., Davatchi, F., et al. (2012). Quality-of-life measurement in blistering diseases. Dermatologic Clinics, 30(2), 301–307.PubMedCrossRef
11.
go back to reference Martin, L. K., Werth, V. P., Villaneuva, E. V., et al. (2011). A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus. Journal of the American Academy of Dermatology, 64(5), 903–908.PubMedCrossRef Martin, L. K., Werth, V. P., Villaneuva, E. V., et al. (2011). A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus. Journal of the American Academy of Dermatology, 64(5), 903–908.PubMedCrossRef
Metagegevens
Titel
Reliability of the autoimmune bullous disease quality of life (ABQOL) questionnaire in the USA
Auteurs
Deshan F. Sebaratnam
Joyce Okawa
Aimee Payne
Dédée F. Murrell
Victoria P. Werth
Publicatiedatum
01-09-2015
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 9/2015
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-015-0965-z

Andere artikelen Uitgave 9/2015

Quality of Life Research 9/2015 Naar de uitgave